Non-Invasive Blood Pressure Measurement in Critically Ill PAtients Post Cardiosurgical Therapy
NCT ID: NCT03710473
Last Updated: 2024-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2019-04-01
2021-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Novel Optical Smartphone Application for Blood Pressure Measurements in Critically Ill Patients
NCT04728477
Non-invasive Validation of Non-invasive Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis
NCT03049709
Invasive Validation of Non-invasive Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis
NCT03046264
Validation of the Aktiia SA PulseWatch OBPM Device at the Wrist Against Invasive Blood Pressure Measurements
NCT03837769
Optical System to Continuously Measure Arterial Blood Pressure
NCT02651558
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the present study the investigators seek to investigate, as a primary purpose, to evaluate the accuracy of non-invasive blood pressure measurements via a watch-like optical sensor and compare these to standard monitoring (arterial line).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optical sensor, Pulse watch
Continuous blood pressure monitoring obtained by a Pulse watch
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing and able to provide Informed Consent.
Exclusion Criteria
* Known severe aortic stenosis (mean gradient \> 40 mmHg, valve area \< 1 cm2);
* Rhythmogenic heart disease (resting heart rate \> 120/min) at time of study inclusion;
* Emergency patient (i.e. unscheduled OR).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ava AG
INDUSTRY
CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Developpement
INDUSTRY
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Reineke, MD
Role: PRINCIPAL_INVESTIGATOR
Dept of Cardiovascular Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Inselspital, Dept of Intensive Care Medicine
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HOPE CT 1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.